ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,793.30
1.44%
S&P ASX All Technology
3,068.10
1.62%
Brent Oil
82.46
-1.22%
US Dollar vs AUD
1.5109
0.08%
Bitcoin
63,445.26
0.43%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Auris Medical Holding AG (EARS)

  7. Auris Medical Holding AG (EARS) News

EARS

Auris Medical (EARS)

Auris Medical Holding AG
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EARS
DateTimeSourceHeadlineSymbolCompany
28/06/202306:46Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
17/06/202307:02Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:EARSAuris Medical Holding AG
16/06/202306:30Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
12/06/202320:44Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EARSAuris Medical Holding AG
12/06/202320:43Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EARSAuris Medical Holding AG
10/06/202306:37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EARSAuris Medical Holding AG
10/06/202306:36Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EARSAuris Medical Holding AG
02/06/202306:32Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:EARSAuris Medical Holding AG
30/05/202322:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
27/05/202307:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
17/05/202306:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
28/04/202306:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EARSAuris Medical Holding AG
18/04/202322:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
18/04/202302:22Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)NASDAQ:EARSAuris Medical Holding AG
13/04/202323:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
13/04/202322:20Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:EARSAuris Medical Holding AG
12/04/202306:02Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:EARSAuris Medical Holding AG
12/04/202306:02Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:EARSAuris Medical Holding AG
03/04/202320:19Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EARSAuris Medical Holding AG
28/03/202301:34Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:EARSAuris Medical Holding AG
23/03/202323:01Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:EARSAuris Medical Holding AG
23/03/202321:05Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:EARSAuris Medical Holding AG
10/03/202308:32Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:EARSAuris Medical Holding AG
10/03/202308:31Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
09/03/202302:11Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:EARSAuris Medical Holding AG
01/03/202308:18Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:EARSAuris Medical Holding AG
17/02/202302:20Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:EARSAuris Medical Holding AG
28/01/202300:51Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:EARSAuris Medical Holding AG
19/01/202308:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EARSAuris Medical Holding AG
28/12/202222:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EARSAuris Medical Holding AG
 Showing the most relevant articles for your search:NASDAQ:EARS

Your Recent History

NASDAQ
MSFT
Microsoft
ASX
CBA
Commonwealth Bank Of Aus...
ASX
CSL
CSL
FX
EURAUD
Euro vs AUD
ASX
AMP
AMP
FX
AUDUSD
AUD vs US Dollar
ASX
SUN
Suncorp
PM
XAUUSD
Gold vs US Dollar
ASX
WDC
Westfield
ASX
ANZ
Australia And New Zealan...
ASX
WES
Wesfarmers
NYSE
MCD
McDonalds
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
XTO
S&P ASX 100
FTSE
UKX
FTSE 100
ASX
BHP
BHP
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved